The ALG11 gene helps cells build sugar chains that must be attached to many proteins so the body can grow, signal, and function normally. This gene plays an important role in early brain and body development, so if it does not work well, some proteins are not processed properly. Pathogenic variants in the ALG11 gene can cause ALG11-CDG, a rare inherited condition that may involve developmental delay, low muscle tone, seizures, feeding problems, and hearing loss. The gene is mainly known in medical genetics rather than in popular culture.

What is a gene?

Genes are stretches of DNA that give cells instructions for making molecules or managing activities in the body. Some genes provide the code for proteins, which do much of the work inside cells. Others mainly regulate when specific processes happen, where they happen, and how active they are. In combination, genes affect how the body grows and works, and they can also influence how you react to food, stress, or medicines. For a deeper look at this subject, you can read more in the LearnHub.

Overview

ALG11

Gene function

What if the gene works

The ALG11 gene helps cells build sugar chains that are attached to many proteins. This supports proper protein folding and helps proteins work normally throughout the body.

Risk

What if the gene does not work

When the ALG11 gene does not work properly, it can cause a congenital glycosylation condition with developmental delay, low muscle tone, seizures, and sometimes hearing loss. Milder or more severe variants can change when symptoms start and how strong they are.

Treatment

What does that mean for your treatment

At present, no ALG11-specific treatment or drug-selection approach is established for people with a pathogenic or loss-of-function variant in the ALG11 gene.

Conditions associated with ALG11

Alg11-cdg

Gene function

What if the gene works

Many proteins need a small sugar tag to work as intended in the body. ALG11 helps build that tag during N-linked glycosylation, a common protein-finishing step inside cells. Understanding what the ALG11 gene does helps explain how cells prepare proteins for normal daily use.

Sugar chain building

ALG11 helps cells add mannose sugar units to a growing sugar chain on a carrier molecule inside the endoplasmic reticulum, the cell area that finishes proteins. This step builds part of the standard tag later placed on many proteins.

Protein finishing

By helping build that sugar tag, this gene supports N-linked glycosylation, a routine process that attaches small sugar chains to proteins. That finishing step helps many proteins fold, travel to the right place, and do their usual jobs.

What is a variant?

A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, such as variations in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.

Variant illustration

Genetic variants

What if the gene does not work

Variants in the ALG11 gene can reduce or stop a step that adds sugar building blocks to newly made proteins, so some proteins are not finished correctly. This is how ALG11 gene variants affect protein function inside the cell. Some variants leave partial enzyme activity, while more disruptive changes can greatly lower protein stability, block its activity, or prevent the protein from being made at all. When little activity remains, ALG11-CDG often starts earlier and tends to be more severe.

How variants are linked to conditions

Pathogenic variants in the ALG11 gene cause ALG11-CDG, also called ALG11 congenital disorder of glycosylation. People with this condition often have developmental delay, low muscle tone, seizures, and feeding difficulties, and some also have vision or hearing problems. The condition is rare and is usually diagnosed when both copies of the ALG11 gene carry a pathogenic variant.

A variant is not necessarily a diagnosis

Variants in genes are a normal feature of human biology and are widespread in the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a certain diagnosis, especially when several genes and environmental factors are involved. In some situations, however, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.

Dr. Wallerstorfer Dr. Wallerstorfer

Are there things that can increase or change my risk?

For ALG11, risk is mainly changed by inheritance rather than lifestyle. A child’s chance of having an ALG11-related condition is higher when both parents carry a harmful change in the ALG11 gene, and this can be more likely in families with shared ancestry or a known family history. There is not enough evidence to say that diet, exercise, or other daily habits lower this genetic risk.

Inheritance of ALG11 variants

ALG11-related conditions are inherited in an autosomal recessive pattern. In plain terms, a child usually needs to inherit one altered copy of the ALG11 gene from each parent to be affected. Parents who each carry one variant in the ALG11 gene are typically unaffected themselves, and with each pregnancy there is a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child who inherits neither variant. This is the key point in understanding how ALG11 gene variants are inherited in families.

What does my ALG11 result mean for my family?

For ALG11, family meaning is usually discussed in terms of a recessive inherited condition. Parents of an affected child are often healthy carriers, and brothers and sisters may also be affected or may be carriers. Other relatives, such as adult siblings of the parents, may also carry the family’s change and may want to learn their carrier status when planning children.


Genetic information


Genetic testing

How you find out about variants

To find out whether you carry a variant in the ALG11 gene, doctors use genetic testing for ALG11 variants on DNA from a blood sample or cheek swab. The lab reads the gene's code and compares it with the usual sequence to identify variants that may help explain symptoms or confirm a diagnosis.

When should I consider getting a genetic test?

Genetic testing for the ALG11 gene may be worth considering when a baby or child has major developmental delay, low muscle tone, feeding problems, seizures, or hearing loss, especially when doctors suspect a rare inherited condition affecting early growth and development. It can also be useful if there is a known ALG11 variant or a similar pattern in the family.

A genetic result is only one part of your health story

A genetic result can provide useful insight, but how much it explains depends on the condition and on the kind of variant involved. How the body functions over time is shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those affected by many genes, genetic information offers context rather than certainty and is most helpful when considered alongside other aspects of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.

Dr. Wallerstorfer Dr. Wallerstorfer

Pharmacogenetics

How variants shape your response to medicine

Genetic variation can affect how people respond to medicines. Small inherited differences can change how the body absorbs, breaks down, transports, or responds to a drug, which helps explain why the same treatment works well for one person but less well for another. These differences are common and may influence how much benefit someone gets from a medicine or how sensitive they are to side effects.

What is Pharmacogenetics?

Pharmacogenetics explores how genetic differences can shape the way a person responds to medications. It studies the relationship between genes and drugs to help explain why the same treatment may work differently from one person to another. With many medicines, genes influence either how strongly a drug works or how the body handles it. This information can support more informed and more individualized treatment decisions. More about this topic is available in the LearnHub.


Drugs influenced by the ALG11 gene

There are 0 Drugs associated with ALG11
Currently no available information

When should I seek medical advice?

There is not yet a broadly confirmed role for this gene in guiding medication choice or response, so any concerns about medicines, side effects, or new health changes are best discussed with your doctor.

DISCLAIMER: The materials present on Genopedia.com, such as text, images, graphics, among other items (“Content”), are shared purely for informational reasons. This content should not replace professional health advice, medical diagnoses, or treatment procedures. Whenever you have health concerns or questions, it’s always recommended to engage with your doctor or another appropriate healthcare provider. If you read something on the Genopedia.com site, do not neglect professional medical counsel or delay in obtaining it. In case you believe you’re dealing with a medical crisis, get in touch with your medical professional or call emergency without delay. Genopedia.com doesn’t advocate for any particular medical tests, healthcare providers, products, methods, beliefs, or other data that could be discussed on the site. Please also note that the content, originally written in English and in part created with the help of artificial intelligence, is provided without any warranty, and any reliance on information offered by Genopedia.com, its staff, contributors invited by Genopedia.com, or site users is entirely at your own risk.
Genopedia © 2026 all rights reserved